372. Prevalence of Anti-Aav8 Neutralizing Antibodies and ARSB Cross-Reactive Immunologic Material in MPS VI Patients Candidates for a Gene Therapy Trial
Molecular Therapy - United States
doi 10.1016/s1525-0016(16)33981-8
Full Text
Open PDFAbstract
Available in full text
Date
May 1, 2015
Authors
Publisher
Elsevier BV